CareDx Inc

CareDx, a Brisbane‑based biotech, delivers innovative heart‑transplant monitoring solutions—stable Nasdaq performance, $1.05 B market cap, and clear insight into its diagnostic services.

CareDx Inc. has maintained a steady performance in the biotechnology sector, despite market fluctuations, with a strong focus on developing diagnostic solutions for heart transplant recipients.

CareDx Inc. is a pioneering biotechnology company that has developed innovative diagnostic solutions to improve heart transplant care, enhancing patient outcomes and reducing healthcare costs.